Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

106 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Model and Empirical Data-Based Cost-Utility Studies of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Protocol of a Systematic Review on Methodology and Quality.
de Jong LA, Li X, Emamipour S, van der Werf S, Postma MJ, van Dijk PR, Feenstra TL. de Jong LA, et al. Among authors: van dijk pr, van der werf s. Pharmacoecon Open. 2023 Nov;7(6):1007-1013. doi: 10.1007/s41669-023-00428-9. Epub 2023 Aug 22. Pharmacoecon Open. 2023. PMID: 37608071 Free PMC article. Review.
Personalizing the Use of a Intermittently Scanned Continuous Glucose Monitoring Device in Individuals With Type 1 Diabetes: A Cost-Effectiveness Perspective in the Netherlands (FLARE-NL 9).
Emamipour S, van Dijk PR, Bilo HJG, Edens MA, van der Galiën O, Postma MJ, Feenstra TL, van Boven JFM. Emamipour S, et al. Among authors: van dijk pr, van boven jfm, van der galien o. J Diabetes Sci Technol. 2024 Jan;18(1):135-142. doi: 10.1177/19322968221109841. Epub 2022 Jul 9. J Diabetes Sci Technol. 2024. PMID: 35815617 Free PMC article.
Evaluating the Cost-Utility of Continuous Glucose Monitoring in Individuals with Type 1 Diabetes: A Systematic Review of the Methods and Quality of Studies Using Decision Models or Empirical Data.
de Jong LA, Li X, Emamipour S, van der Werf S, Postma MJ, van Dijk PR, Feenstra TL. de Jong LA, et al. Among authors: van dijk pr. Pharmacoeconomics. 2024 Sep;42(9):929-953. doi: 10.1007/s40273-024-01388-6. Epub 2024 Jun 21. Pharmacoeconomics. 2024. PMID: 38904911 Free PMC article.
Phosphate and fibroblast growth factor 23 in diabetes.
van der Vaart A, Yeung SMH, van Dijk PR, Bakker SJL, de Borst MH. van der Vaart A, et al. Among authors: van dijk pr. Clin Sci (Lond). 2021 Jul 30;135(14):1669-1687. doi: 10.1042/CS20201290. Clin Sci (Lond). 2021. PMID: 34283205 Free PMC article. Review.
106 results